ArticleNPJ precision oncology2024

Amivantamab efficacy in wild-type EGFR NSCLC tumors correlates with levels of ligand expression.

Ricardo Rivera-Soto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.